中华中医药学刊

中药黄酮类成分抗消化道肿瘤作用机制的研究进展

PDF下载

杨振耀 ¹ , 王成志 ¹ , 李文君 ¹ , 郑成垒 ¹ , 张晓青 ² , 刘培民 ¹ , 李东东 ¹

中华中医药学刊 | 国家项目点击 2026,44(4): 182-189

收起

中华中医药学刊 |国家项目点击 2026 , 44 (4) : 182 -189

中药黄酮类成分抗消化道肿瘤作用机制的研究进展

全屏

杨振耀¹, 王成志¹, 李文君¹, 郑成垒¹, 张晓青², 刘培民¹, 李东东¹

作者信息

^1.河南中医药大学第二附属医院，河南郑州 450002

^2.郑州大学第一附属医院，河南郑州 450052

通讯作者:

刘培民（1973-），男，山东枣庄人，教授，博士，研究方向：中医药防治恶性肿瘤的临床及基础。E-mail: lpm2020@163.com。

李东东（1989-），男，河南开封人，主治医师，博士，研究方向：中医药防治恶性肿瘤的临床及基础。E-mail: dongdongli2018@126.com。

作者简介:

杨振耀（2000-），男，河南安阳人，硕士在读，研究方向：中医药防治恶性肿瘤的临床及基础。

Research Progress on Mechanisms of Flavonoids in Traditional Chinese Medicine Against Gastrointestinal Tumor

Zhenyao YANG¹, Chengzhi WANG¹, Wenjun LI¹, Chenglei ZHENG¹, Xiaoqing ZHANG², Peimin LIU¹, Dongdong LI¹

Affiliations

^1.The Second Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450002, Henan, China

^2.The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China

出版时间: 2026-04-10 doi: 10.13193/j.issn.1673-7717.2026.04.036

文章导航

摘要

收起

消化道肿瘤的发病率及死亡率在我国均位居前列，为社会带来巨大的医疗负担。为寻求更好的疗效，针对肿瘤的治疗越来越多样化，近年来中医药在抗肿瘤方面的作用被发掘发展，中药可在中医理论指导下发挥扶正祛邪抗肿瘤的作用。黄酮类化合物是诸多中药主要有效成分之一，具备多靶点、多途径、低毒性等优势，且可促进胃肠道健康，防治胃肠道疾病。因此，黄酮类化合物治疗消化道肿瘤具备一定的优势。现代研究表明，黄酮类化合物如黄芩苷、槲皮素、木犀草素、异甘草素、川陈皮素等可通过调控细胞自噬、细胞焦亡、线粒体凋亡、铁死亡、上皮间充质转化（Epithelial-mesenchymal transition，EMT）、肿瘤相关巨噬细胞（Tumor-associated macrophages，TAMs）、微RNA（microRNA，miRNA）、血管生成、代谢重编程、甲基化等多种方式发挥抗消化道肿瘤作用。筛选梳理近年来国内外黄酮类化合物治疗消化道肿瘤的研究，总结黄酮类化合物抗消化道肿瘤的作用机制，以期支持黄酮类化合物在消化道肿瘤治疗中的进一步探讨，推动黄酮类化合物的深入研究及在临床中的开发应用。

关键词

消化道肿瘤 / 黄酮 / 中药 / 作用机制 / 研究进展

Abstract

收起

The incidence and mortality of gastrointestinal tumors are among the highest in China, posing a significant medical burden on society. In search of better therapeutic effects, the treatment of tumors has become increasingly diversified. In recent years, the role of traditional Chinese medicine（TCM）in cancer treatment has been explored and developed. Under the guidance of TCMtheory, herbal medicines can enhance the body＇s resistance and remove malign influences to combat tumors. Flavonoids, as one of the main effective components in many herbal medicines, have multiple advantages including multi-target effects, multi-pathway interactions and low toxicity. They can also promote gastrointestinal health and prevent gastrointestinal diseases. Therefore, flavonoids have certain advantages in treating gastrointestinal tumors. Modern research has shown that flavonoids such as baicalin, quercetin, luteolin, isoliquiritigenin and hesperidin can exert anti-tumor effects through various mechanisms including regulating autophagy, pyroptosis, mitochondrial apoptosis, ferroptosis, epithelial-mesenchymal transition（EMT）, tumor-associated macrophages（TAMs）, microRNA（miRNA）, angiogenesis, metabolic reprogramming and methylation. This paper reviewed recent domestic and international research on flavonoids in the treatment of gastrointestinal tumors, summarized the mechanisms of flavonoids against gastrointestinal tumors, and supported further discussion on the use of flavonoids in gastrointestinal tumor treatment, promoting in-depth research and clinical development of flavonoids.

Key words

gastrointestinal tumors / flavonoids / traditional Chinese medicine / mechanisms of action / research progress

引用本文

杨振耀, 王成志, 李文君, 郑成垒, 张晓青, 刘培民, 李东东. 中药黄酮类成分抗消化道肿瘤作用机制的研究进展. 中华中医药学刊, 2026 , 44 (4) : 182 -189 . DOI: 10.13193/j.issn.1673-7717.2026.04.036

Zhenyao YANG, Chengzhi WANG, Wenjun LI, Chenglei ZHENG, Xiaoqing ZHANG, Peimin LIU, Dongdong LI. Research Progress on Mechanisms of Flavonoids in Traditional Chinese Medicine Against Gastrointestinal Tumor[J]. Chinese Archives of Traditional Chinese Medicine, 2026 , 44 (4) : 182 -189 . DOI: 10.13193/j.issn.1673-7717.2026.04.036

基金

收起

国家自然科学基金项目(82204981)
国家中医临床研究基地科研专项(2021JDZX2002)
河南省特色骨干学科中医学学科建设项目(STG-ZYX06-202145)
河南省中医药科学研究专项(20-21ZY2115)
河南省中医院博士科研基金项目(2022BSJJ08; 2023BSJJ02)
河南中医药大学研究生科研创新能力提升计划项目(2022KYCX057; 2023KYCX043; 2023KYCX051)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

[1]

BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality world-wide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74（3）: 229-263.

[2]

CAO W, CHEN H D, YU Y W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J（Engl）, 2021, 134（7）: 783-791.

[3]

ZHANG Y, LOU Y N, WANG J B, et al. Research status and molecular mechanism of the traditional Chinese medicine and antitumor therapy combined strategy based on tumor microenvironment [J]. Front Immunol, 2021, 11: 609705.

[4]

FU J Y, XIE X X, YAO H M, et al. The effectiveness of traditional Chinese medicine in treating malignancies via regulatory cell death pathways and the tumor immune microenvironment: a review of recent advances[J]. Am J Chin Med, 2024, 52（1）: 137-160.

[5]

ROMAGNOLO D F, SELMIN O I. Flavonoids and cancer prevention: a review of the evidence[J]. J Nutr Gerontol Geriatr, 2012, 31（3）: 206-238.

[6]

BISOL Â, DE CAMPOS P S, LAMERS ML. Flavonoids as anticancer therapies: a systematic review of clinical trials[J]. Phytother Res, 2020, 34（3）: 568-582.

[7]

SINGH S, VERMA R. Exploring the therapeutic potential of flavonoids in the management of cancer[J]. Curr Pharm Biotechnol, 2025, 26（1）: 17-47.

[8]

常化松，袁雯雯，玄红专，等.黄酮类化合物吸收代谢及其对胃肠道功能影响的研究进展[J].食品工业科技，2019，40（18）：340-347.

[9]

李夏平，殷东风，邢玉庆，等.恶性肿瘤中医病名初探[C]//中华中医药学会中医、中西医结合治疗常见病研讨会论文集.黄山，2007：37-40.

[10]

靖林林，孙学刚.基于肿瘤微环境病机的抗癌策略探讨[J].中华中医药杂志，2017，32（11）：5001-5004.

[11]

朱燃培，张华，李小青，等.鳖甲煎丸抗肝癌的作用机制和临床研究进展[J].中国实验方剂学杂志，2023，29（18）：267-276.

[12]

王钰涵，靳明明，吕昌莲.加减乌梅丸对结直肠癌治疗的研究进展[J].中华中医药学刊，2024，42（4）：184-188.

[13]

WANG X B, MA Y, XU Q H, et al. Flavonoids and saponins: what have we got or missed？ [J]. Phytomedicine, 2023, 109: 154580.

[14]

WEN K M, FANG X C, YANG J L, et al. Recent research on flavonoids and their biomedical applications [J]. Curr Med Chem, 2021, 28（5）: 1042-1066.

[15]

THEIN W, PO W W, CHOI W S, et al. Autophagy and digestive disorders: advances in understanding and therapeutic approaches[J]. Biomol Ther（Seoul）, 2021, 29（4）: 353-364.

[16]

SHI S W, YI L. Autophagy and its relationship with tumor proliferation, invasion, and treatment[J]. Huaxi Kouqiang Yixue Zazhi, 2015, 33（1）: 98-103.

[17]

NAZIM U M, PARK S Y. Luteolin sensitizes human liver cancer cells to TRAIL-induced apoptosis via autophagy and JNK-mediated death receptor 5 upregulation[J]. Int J Oncol, 2019, 54（2）: 665-672.

[18]

陈娟，邓敏，周焕，等.木犀草素抑制PKM2继而促进自噬诱导肝癌细胞凋亡[J].中国医院药学杂志，2021，41（11）：1103-1108.

[19]

乔丹，李英顺，邢健，等.黄芩素抑制磷脂酰肌醇3激酶/蛋白激酶B（PI3K/AKT）信号通路并诱导MGC-803细胞自噬[J].细胞与分子免疫学杂志，2019，35（7）：613-618.

[20]

杨金旭，孙自红，徐琳.马鞭草总黄酮通过AKT/mTOR信号通路调控自噬抑制肝癌细胞增殖[J].现代肿瘤医学，2023，31（14）：2631-2638.

[21]

WANG R H, SHANG B B, WU S X, et al. Recent updates on pyroptosis in tumors of the digestive tract[J]. J Dig Dis, 2023, 24（12）: 640-647.

[22]

ZHANG Y, YANG H, SUN M F, et al. Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis [J]. Pharmacol Rep, 2020, 72（5）: 1370-1382.

[23]

ZHANG B, ZHU W Y, TIAN H, et al. Alpinumisoflavone triggers GSDME-dependent pyroptosis in esophageal squamous cell carcinomas[J]. Anat Rec（Hoboken）, 2021, 304（2）: 323-332.

[24]

CHEN Y L, MA S S, PI D J, et al. Luteolin induces pyroptosis in HT-29 cells by activating the Caspase1/Gasdermin D signalling pathway[J]. Front Pharmacol, 2022, 13: 952587.

[25]

HAQUE P S, KAPUR N, BARRETT T A, et al. Mitochondrial function and gastrointestinal diseases [J]. Nat Rev Gastroenterol Hepatol, 2024, 21: 537-555.

[26]

WANG J R, LUO Y H, PIAO X J, et al. Mechanisms underlying isoliquiritigenin-induced apoptosis and cell cycle arrest via ROS-mediated MAPK/STAT3/NF-κB pathways in human hepatocellular carcinoma cells[J]. Drug Dev Res, 2019, 80（4）: 461-470.

[27]

WANG J R, LI T Z, WANG C, et al. Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway[J]. Naunyn Schmiedebergs Arch Pharmacol, 2020, 393（10）: 1987-1999.

[28]

ZHANG Y, ZHANG J Q, ZHANG T, et al. Calycosin induces gastric cancer cell apoptosis via the ROS-mediated MAPK/STAT3/NF-κB pathway [J]. Onco Targets Ther, 2021, 14: 2505-2517.

[29]

RAO X H, ZHANG C J, LUO H X, et al. Targeting gastric cancer stem cells to enhance treatment response [J]. Cells, 2022, 11（18）: 2828.

[30]

杜亚青，李向英，张丽晓，等.毛蕊异黄酮抑制胃癌干细胞样细胞的增殖、迁移与侵袭并诱导凋亡[J].中国病理生理杂志，2023，39（1）：37-44.

[31]

罗颖懿，李运容，雷胄熙，等.铁皮石斛共性黄酮类成分新西兰牡荆苷Ⅱ的体外抗氧化与诱导HepG2细胞凋亡的作用[J].中国实验方剂学杂志，2019，25（1）：43-50.

[32]

ZHANG R X, KANG R, TANG D L. Ferroptosis in gastrointestinal cancer: from mechanisms to implications[J]. Cancer Lett, 2023, 561: 216147.

[33]

WANG C X, CHEN L H, ZHUANG H B, et al. Auriculasin enhances ROS generation to regulate colorectal cancer cell apoptosis, ferroptosis, oxeiptosis, invasion and colony formation[J]. Biochem Biophys Res Commun, 2022, 587: 99-106.

[34]

WANG Z X, MA J, LI X Y, et al. Quercetin induces p53-independent cancer cell death via Tfeb-mediated lysosome activation and ros-dependent ferroptosis[J]. Br J Pharmacol, 2020, 178: 1133-1148.

[35]

LIU X, PENG X H, CEN S, et al. Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis[J]. Front Pharmacol, 2023, 14: 1129662.

[36]

ZHOU L, YANG C, ZHONG W L, et al. Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells[J]. Biochem Pharmacol, 2021, 193: 114813.

[37]

苑小龙，魏征，张俊萍，等.黄芩苷通过p53介导的SLC7A11下调诱导胃癌细胞铁死亡[J].中国实验方剂学杂志，2023，29（6）：71-78.

[38]

ZHOU J Q, LI H J, ZENG Y H, et al. Baicalin induces ferroptosis in HepG2 cells by inhibiting ROS-mediated PI3K/Akt/FoxO3a signaling pathway[J]. Zhongguo Zhong Yao Za Zhi, 2024, 49（5）: 1327-1334.

[39]

FAN H C, LIN S Z, HARN H J. Targeting epithelial-mesenchymal transition phenotype for gastro-intestinal cancer [J]. Curr Pharm Des, 2015, 21（21）: 2942-2955.

[40]

LIN Y T, WU K J. Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-βsignaling[J]. J Biomed Sci, 2020, 27（1）: 39.

[41]

ZHOU P, ZHENG Z H, WAN T, et al. Vitexin inhibits gastric cancer growth and metastasis through HMGB1-mediated inactivation of the PI3K/AKT/mTOR/HIF-1 αsignaling pathway[J]. J Gastric Cancer, 2021, 21（4）: 439-456.

[42]

贺文煜，张海明，余涛，等.高良姜素对缺氧诱导因子-1 α诱导胃癌细胞上皮间质转化的作用机制[J].中国药理学通报，2023，39（5）：839-843.

[43]

张雯，张小占，卢朝辉.黄芩黄酮Ⅰ对结直肠癌细胞迁移、侵袭和上皮-间质转化的影响[J].中国临床药理学杂志，2021，37（22）：3076-3078.

[44]

杨雪竹，张浩，崔西玉，等.川陈皮素抑制胃癌SGC-7901细胞侵袭能力的机制探讨[J].现代肿瘤医学，2020，28（18）：3099-3104.

[45]

XING S, YU W, ZHANG X, et al. Isoviolanthin extracted from Dendrobium officinale reverses TGF-β1-mediated Epithelial？ Mesenchymal transition in hepatocellular carcinoma cells via deactivating the TGF-β/smad and PI3K/Akt/mTOR signaling pathways[J]. Int J Mol Sci, 2018, 19（6）: E1556.

[46]

CASSETTA L, POLLARD J W. Targeting macrophages: therapeutic approaches in cancer[J]. Nat Rev Drug Discov, 2018, 17（12）: 887-904.

[47]

WU R X, ZHOU T, XIONG J Q, et al. Quercetin, the ingredient of Xihuang pills, inhibits hepatocellular carcinoma by regulating autophagy and macrophage polarization[J]. Front Biosci（Landmark Ed）, 2022, 27（12）: 323.

[48]

ZHU Y Z, FAN W N, WANG Y Z, et al. Flavokawain B weakens gastric cancer progression via the TGF-β1/SMAD4 pathway and attenuates M2 macrophage polarization[J]. J Immunol Res, 2022, 2022: 4903333.

[49]

CHEN Y E, WANG B X, YUAN X, et al. Vitexin prevents colitis-associated carcinogenesis in mice through regulating macrophage polarization[J]. Phytomedicine, 2021, 83: 153489.

[50]

ZHANG F Q, LUO H. Diosmetin inhibits the growth and invasion of gastric cancer by interfering with M2 phenotype macrophage polarization[J]. J Biochem Mol Toxicol, 2023, 37（10）: e23431.

[51]

TAMC, WONG J H, TSUI S K W, et al. LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years [J]. Appl Microbiol Biotechnol, 2019, 103（12）: 4649-4677.

[52]

ZHOU S F, GUO Z Z, ZHOU C F, et al.circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma（ESCC） via miR-595/SEMA4D axis and PI3K/AKT pathway[J]. Cancer Cell Int, 2021, 21（1）: 250.

[53]

LUO T X, GUAN H Y, LIU J, et al. Curcumin inhibits esophageal squamous cell carcinoma progression through down-regulating the circNRIP1/miR-532-3p/AKT pathway[J]. Environ Toxicol, 2023, 38（11）: 2705-2716.

[54]

YANG P W, LU Z Y, PAN Q, et al.microRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1 [J]. Phytomedicine, 2019, 57: 18-29.

[55]

YAO Y, RAO C, ZHENG G, et al. Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR-384/pleiotrophin axis[J]. Oncol Rep, 2019, 42（1）: 131-141.

[56]

CHEN L T, OH D Y, RYU MH, et al. Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: a systematic review[J]. Cancer Res Treat, 2017, 49（4）: 851-868.

[57]

JAIN R K. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia [J]. Cancer Cell, 2014, 26（5）: 605-622.

[58]

LI X, LI Y, WANG Y, et al. Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF/VEGFR2/AKT signaling pathway[J]. Exp Ther Med, 2022, 23（5）: 360.

[59]

KIMMJ, PARAMANANTHAMA, LEE W S, et al. Anthocyanins derived from Vitis coignetiae pulliat contributes anti-cancer effects by suppressing NF-κB pathways in Hep3B human hepatocellular carcinoma cells and in vivo[J]. Molecules, 2020, 25（22）: 5445.

[60]

宋浩然，林续涛，王东，等.羟基红花黄色素A增强LY294002对人肝癌裸鼠移植瘤生长和血管生成的抑制[J].中国组织化学与细胞化学杂志，2022，31（2）：146-151，167.

[61]

王毓睿.黄芩及其主要成分通过改善胰腺癌炎性微环境抑制血管生成的机制探究[D].天津：天津中医药大学，2022.

[62]

ERDOĞAN M K, AĞCA C A, AŞKIN H. Quercetin and luteolin improve the anticancer effects of 5-fluorouracil in human colorectal adenocarcinoma in vitro model: a mechanistic insight [J]. Nutr Cancer, 2022, 74（2）: 660-676.

[63]

TOSOC J P S, NUÑEZA O M, SUDHA T, et al. Anticancer effects of the Corchorus olitorius aqueous extract and its bioactive compounds on human cancer cell lines[J]. Molecules, 2021, 26（19）: 6033.

[64]

LIU J F, WANG T X, ZHANG W X, et al. Association between metabolic reprogramming and immune regulation in digestive tract tumors[J]. Oncol Res Treat, 2024, 47（6）: 273-286.

[65]

GUO D L, JIN J, LIU J H, et al. Baicalein inhibits the progression and promotes radiosensitivity of esophageal squamous cell carcinoma by targeting HIF-1 A [J]. Drug Des Devel Ther, 2022, 16: 2423-2436.

[66]

PAN G T, ZHANG P, CHEN A Y, et al. Aerobic glycolysis in colon cancer is repressed by naringin via the HIF1 Αpathway[J]. J Zhejiang Univ Sci B, 2023, 24（3）: 221-231.

[67]

NOH K H, KANG H M, YOO W, et al. Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression [J]. Metabolism, 2020, 110: 154302.

[68]

申隽于，李怀志，陈梦麟，等.基于多组学探讨川陈皮素调控脂质合成氧化逆转胃癌顺铂耐药的机制[J].中草药，2023，54（21）：7066-7077.

[69]

SHAO H, CHEN J Y, LI A L, et al. Salvigenin suppresses hepatocellular carcinoma glycolysis and chemoresistance through inactivating the PI3K/AKT/GSK-3βpathway[J]. Appl Biochem Biotechnol, 2023, 195（8）: 5217-5237.

[70]

DAI X F, REN T J, ZHANG Y X, et al. Methylation multiplicity and its clinical values in cancer[J]. Expert Rev Mol Med, 2021, 23: e2.

[71]

JIANG H P, YAO Q Q, AN Y B, et al. Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m6A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway [J]. Phytomedicine, 2022, 94: 153823.

[72]

HUANG C J, ZHOU S H, ZHANG C L, et al. ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer[J]. Cancer Lett, 2022, 530: 16-28.

[73]

ZHU J, REN J, TANG L M. Genistein inhibits invasion and migration of colon cancer cells by recovering WIF1 expression[J]. Mol Med Rep, 2018, 17（5）: 7265-7273.

2026年第44卷第4期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.13193/j.issn.1673-7717.2026.04.036

首发时间：2026-10-14
出版时间：2026-04-10

补充材料

相关文章

文章信息

作者

出版历史

基金

国家自然科学基金项目(82204981)

国家中医临床研究基地科研专项(2021JDZX2002)

河南省特色骨干学科中医学学科建设项目(STG-ZYX06-202145)

河南省中医药科学研究专项(20-21ZY2115)

河南省中医院博士科研基金项目(2022BSJJ08; 2023BSJJ02)

河南中医药大学研究生科研创新能力提升计划项目(2022KYCX057; 2023KYCX043; 2023KYCX051)

作者信息

^1.河南中医药大学第二附属医院，河南郑州 450002

^2.郑州大学第一附属医院，河南郑州 450052

通讯作者:

刘培民（1973-），男，山东枣庄人，教授，博士，研究方向：中医药防治恶性肿瘤的临床及基础。E-mail: lpm2020@163.com。

李东东（1989-），男，河南开封人，主治医师，博士，研究方向：中医药防治恶性肿瘤的临床及基础。E-mail: dongdongli2018@126.com。

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zhzyyxk/CN/10.13193/j.issn.1673-7717.2026.04.036

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT